Despite the acknowledged limitations, these two metanalyses reach a consistent conclusion: the combination of SGLT2i and GLP-1RA is associated with significantly lower all-cause mortality and superior cardiorenal outcomes compared to monotherapy in patients with T2DM

Contact your GP or healthcare provider if you experience: Dark amber or brown urine persisting despite increased fluid intake, which may indicate severe dehydration or, rarely, liver dysfunction Urine colour changes accompanied by symptoms such as persistent vomiting, inability to tolerate oral fluids, severe diarrhoea, or abdominal pain Signs of dehydration : Dizziness, lightheadedness, dry mouth, passing urine less often than usual, dark or strong-smelling urine, or rapid heartbeat Red, pink, or cola-coloured urine : May indicate haematuria (blood in urine), requiring investigation for urinary tract pathology Cloudy or foul-smelling urine with dysuria : Suggests possible urinary tract infection Pale or clay-coloured stools with dark urine and jaundice : Rare but serious indicators of biliary obstruction or hepatic dysfunction For urgent advice : Contact NHS 111 if you cannot reach your GP and need help quickly

Recent studies have measured in vivo GSH in the brain using magnetic resonance spectroscopy (MRS) and peripherally in the blood [21,22,23]
J., Sutherland, G
Blevins, B